CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −23 | $199.22 | $5K | 44,151 |
| 2025-12-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −30 | $200.02 | $6K | 44,121 |
| 2025-11-07 | Gray Nancy Ryan Director | Option exercise | +3,556 | $66.19 | $235K | 11,650 |
| 2025-11-07 | Gray Nancy Ryan Director | Sale | −3,556 | $205.45 | $731K | 8,094 |
| 2025-11-07 | Gray Nancy Ryan Director | Option exercise | +3,015 | $73.57 | $222K | 11,109 |
| 2025-11-07 | Gray Nancy Ryan Director | Sale | −3,015 | $205.45 | $619K | 8,094 |
| 2025-11-07 | Gray Nancy Ryan Director | Option exercise · Non-Qualified Stock Option (right to buy) | −3,556 | 0 | ||
| 2025-11-07 | Gray Nancy Ryan Director | Option exercise · Non-Qualified Stock Option (right to buy) | −3,015 | 0 | ||
| 2025-11-07 | LAMATTINA JOHN L Director | Option exercise | +2,145 | $66.13 | $142K | 32,869 |
| 2025-11-07 | LAMATTINA JOHN L Director | Sale | −2,145 | $205.45 | $441K | 30,724 |
| 2025-11-07 | LAMATTINA JOHN L Director | Option exercise | +2,034 | $69.51 | $141K | 32,758 |
| 2025-11-07 | LAMATTINA JOHN L Director | Sale | −2,034 | $205.45 | $418K | 30,724 |
| 2025-11-07 | LAMATTINA JOHN L Director | Option exercise · Non-Qualified Stock Option (right to buy) | −2,145 | 0 | ||
| 2025-11-07 | LAMATTINA JOHN L Director | Option exercise · Non-Qualified Stock Option (right to buy) | −2,034 | 0 | ||
| 2025-11-03 | KOZARICH JOHN W Director | Sale 10b5-1 | −84 | $189.00 | $16K | 44,971 |
| 2025-11-03 | KOZARICH JOHN W Director | Sale 10b5-1 | −49 | $190.26 | $9K | 44,922 |
| 2025-11-03 | KOZARICH JOHN W Director | Sale 10b5-1 | −207 | $191.25 | $40K | 44,715 |
| 2025-11-03 | KOZARICH JOHN W Director | Sale 10b5-1 | −127 | $192.38 | $24K | 44,588 |
| 2025-10-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −24 | $177.60 | $4K | 45,498 |
| 2025-10-01 | KOZARICH JOHN W Director | Sale 10b5-1 | −196 | $178.41 | $35K | 45,302 |
Page 14 of 43 · 858 trades